Dopamine Flashcards
Class
Sympathomimetic, inotropic agent
MOA
Stimulates alpha, beta, and dopaminergic receptors in a dose dependent fashion. Increases systemic vascular resistance. Causes peripheral vasoconstriction, but dilates renal, mesenteric and cerebral vasculature at low doses. Increases inotropic and chronotropic effects on the heart.
Indications
Cardiogenic shock. Distributive shock – septic, spinal, anaphylaxis (Anaphylaxis refractory to epinephrine and fluid boluses). Hypotension with low cardiac output states. Bradycardia refractory to atropine and pacing. Crush injuries.
Contraindications
Hypovolemic shock, pheochromocytoma, tachyarrhythmias, v-fib
Adverse reactions
Cardiac arrhythmias- tachycardias, hypertension, increased myocardial oxygen demand; extravasation may cause tissue necrosis
Drug Interactions
Incompatible with alkaline solutions. MAOIs will enhance the effects of dopamine. Bretylium may potentiate effect of dopamine. Beta-blockers may antagonize the effects of dopamine. When administered with phenytoin; may cause hypotension, bradycardia, and seizures
Dosage
Adult: IV infusion at 2 – 20 mcg/kg/min titrated to effect
400 mg in 250 ml (or 800mg/500ml or 1600mg/1000mL)
Pediatric: 2 – 20 mcg/kg/min titrated to effect
Duration
Onset: 1 – 4 minutes
Peak effects: 5 – 10 minutes
Duration: Effects stop almost immediately after infusion is stopped
Special Considerations
Effects are dose dependent
1 - 2 mcg/kg/min: dilates vessels in kidneys; increased urine output.
5 – 10 mcg/kg/min: increased heart rate (beta effects)
10 – 20 mcg/kg/min: primarily vasoconstriction (alpha effects)
Extravasation will cause tissue necrosis and sloughing.
Abrupt termination may cause acute hypotension, discontinue gradually.
Pregnancy category
C
Supplied
400 mg in 5 mL, MUST be added to 250 mL bag normal saline to make 1600mcg/mL. Premixed bag 800 mg in 500 mL